ANDA 90343, held by Inforlife. Levofloxacin.
As of Nov 16, 2026, ANDA 90343 (Levofloxacin In Dextrose 5% In Plastic Container), held by Inforlife, was first approved by FDA on Jul 7, 2011, with 11 approved supplements and 0 published complete response letters.
Levofloxacin Injection in 5% dextrose is indicated for the treatment of adults (≥18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. Levofloxacin Injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). Levofloxacin is a fluoroquinolone antibacterial indicated in adults (≥18 years of age) with infections caused by designated, susceptible bacteria ( 1, 12.4 ). Pneumonia: Nosocomial and Community Acquired ( 1.2, 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 7, 2011 | Original application | Approved | None posted |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 250MG/50ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Rx |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 500MG/100ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Rx |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 750MG/150ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Rx |
| Sep 26, 2024 | Supplement 32Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 27Labeling · Standard review | Approved | None posted |
| Apr 17, 2019 | Supplement 24Labeling · Standard review | Approved | None posted |
| Apr 17, 2019 | Supplement 22Labeling · Standard review | Approved | None posted |
| Oct 18, 2018 | Supplement 26Labeling · Standard review | Approved | None posted |
| Nov 8, 2014 | Supplement 18Labeling · Standard review | Approved | None posted |
| Nov 8, 2014 | Supplement 16Labeling · Standard review | Approved | None posted |
| Nov 28, 2012 | Supplement 12Labeling · Standard review | Approved | None posted |
| Mar 29, 2012 | Supplement 6REMS | Approved | None posted |
| Feb 10, 2012 | Supplement 4Labeling | Approved | None posted |
| Oct 20, 2011 | Supplement 1Labeling | Approved | None posted |
| Jul 7, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters